Nivin Pauly, fresh off his OTT debut in 'Pharma' and the feel-good hit 'Sarvam Maya,' is gearing up for a busy 2026 with five ...

Get all latest & breaking news on Dino Morea. Watch videos, top stories and articles on Dino Morea at moneycontrol.com.

In a serendipitous twist, Krystle D’Souza reflects on her inclusion in the '#Shararat' track from 'Dhurandhar', stepping into a role originally meant for the talented Tamannaah Bhatia. Recognizing ...

In a playful tease, Krystle D'Souza has sparked buzz around her potential return in 'Dhurandhar Part 2,' saying, "Stay tuned!" While keeping fans on the edge of their seats, she reflected on fate and ...

Handelnine Global Limited d/b/a Navafresh is voluntarily recalling Lot Numbers CAM040 & CALO79-N of Rheumacare Capsules by Virgo UAP Pharma Pvt. Ltd. (Virgo) to the consumer level. In test conducted ...

Drugmakers will cut prices on most drugs sold to Medicaid to most-favored-nation pricing, matching the lowest prices anywhere in the world, Trump said. Companies agreed to list drugs on TrumpRx.gov, a ...

Despite a year of trade tensions, national security strictures and stark warnings about the U.S.’ waning biotech innovation edge, the fact remains that China is and will likely continue to be a ...

Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay, in a new round of industry pacts with ...

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S.

Goldman Sachs and Quadria Capital-backed Aragen Life Sciences is expanding India’s role in its global operations as demand ...

AstraZeneca said its experimental drug ceralasertib in combination with approved cancer treatment Imfinzi didn’t meet the primary goal of a late-stage clinical trial for advanced lung cancer. The U.K.

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer ...